🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of Tylenol, alleging the firms concealed safety concerns that the pain reliever created to children's neurological development.

The court filing follows thirty days after Former President Trump promoted an unsubstantiated connection between consuming Tylenol - also known as paracetamol - during pregnancy and autism spectrum disorder in young ones.

The attorney general is suing J&J, which once produced the medication, the sole analgesic recommended for pregnant women, and Kenvue, which currently produces it.

In a statement, he said they "betrayed America by gaining financially from pain and marketing drugs regardless of the potential hazards."

Kenvue states there is no credible evidence linking Tylenol to autism.

"These manufacturers deceived for years, intentionally threatening millions to boost earnings," the attorney general, from the Republican party, declared.

The manufacturer said in a statement that it was "deeply concerned by the spread of false claims on the reliability of acetaminophen and the possible consequences that could have on the health of American women and children."

On its website, the company also said it had "continuously evaluated the pertinent research and there is insufficient valid information that indicates a verified association between consuming paracetamol and autism."

Associations speaking for physicians and health professionals share this view.

The leading OB-GYN organization has stated acetaminophen - the primary component in acetaminophen - is among limited choices for pregnant women to address discomfort and elevated temperature, which can create serious health risks if ignored.

"In over twenty years of studies on the utilization of paracetamol in pregnancy, no reliable research has conclusively proven that the consumption of paracetamol in any period of gestation results in neurodevelopmental disorders in young ones," the group stated.

The lawsuit references recent announcements from the former administration in claiming the drug is potentially dangerous.

In recent weeks, the former president generated worry from medical authorities when he advised expectant mothers to "struggle intensely" not to take Tylenol when ill.

The US Food and Drug Administration then released a statement that medical professionals should think about restricting the usage of acetaminophen, while also mentioning that "a proven link" between the medication and autism in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had pledged in April to conduct "comprehensive study program" that would determine the cause of autism spectrum disorder in a short period.

But experts warned that identifying a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that influences how people perceive and engage with the world, and is identified using doctors' observations.

In his court filing, Paxton - aligned with the former president who is campaigning for federal office - claims Kenvue and J&J "deliberately disregarded and attempted to silence the evidence" around paracetamol and autism spectrum disorder.

The case aims to force the firms "eliminate any promotional materials" that claims Tylenol is reliable for women during pregnancy.

The court case echoes the grievances of a group of guardians of children with autism and ADHD who filed suit against the manufacturers of Tylenol in recently.

A federal judge threw out the legal action, declaring investigations from the plaintiffs' authorities was inconclusive.